Donanemab
Účinná látka · 1 přípravek na trhu
- Mezinárodní název (INN)
- Donanemabum
- Anglicky
- DONANEMAB
Synonyma: 1931944-80-7 · DONANEMAB · DONANEMABUM · IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS APP (AMYLOID BETA A4 PRECURSOR PROTEIN) A BETA 3-PYROGLUTAMYL PEPTIDES, A BETA 3 (3-X)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-444) [VH (HOMO SAPIENS IGHV1- 3*01 (84.7%) -(IGHD) -IGHJ4*01 (91.7%)) [8.8.8] (1-115) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (212) (116-213), HINGE (214-228), CH2 (229-338), CH3 D12 (354), L14 (356) (339- 443), CHS K2>DEL (444)) (116-444)], (218-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') [V-KAPPA (HOMO SAPIENS IGKV2- 29*02 (89.0%) -IGKJ2*02 (100%)) [11.3.9] (1'-112') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (158), V101 (196) (113'-219')]; DIMER (224-224'':227-227'')-BISDISULFIDE. REC. INN: LIST 82
- Kisunla 350 mg Koncentrát pro infuzní roztok na předpis